vimarsana.com

கலிஃபோர்னியா செனட் ஆரோக்கியம் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

California s SB-642 Targets Hospitals and Management Services Organizations | Mintz - Health Care Viewpoints

To embed, copy and paste the code into your website or blog: On May 3, 2021, the California Senate Health Committee approved SB-642 “Health care: facilities: medical privileges.” The bill is currently pending in the California Senate. AB-705, which is substantially similar to SB-642, is also pending in the California Assembly.  If passed, the law will curtail hospital governing bodies’ ability to make decisions about the medical services provided at the facility without medical staff approval, impose new limitations on arrangements between management services organizations and professional corporations, and add additional factors to the Attorney General’s review and approval of nonprofit health care facility transactions.

Corporate Practice of Medicine on Steroids | Buchalter

To embed, copy and paste the code into your website or blog: At a time when many are questioning the continued utility and viability of the corporate practice of medicine ban, California may be doubling down. On May 3, 2021, the California Senate Health Committee approved SB-642, the stated purpose of which is to protect medical decision-making from lay control. The bill is currently pending in the California Senate. Assembly Bill AB-705 is a substantially identical bill in the California Assembly. The SB-642 adds Section 2408.5 to the Business and Professions Code, as follows: 2408.5 . (a) The shareholders, directors, and officers of a medical corporation as set forth in Section 2408 shall manage and have ultimate control over the assets and business operations of the medical corporation and shall not be replaced, removed, or otherwise controlled by any lay entity or individual, including, without limitation, through stock transfer restriction agreements or other contractual a

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.